找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Advances in Cancer Treatment; From Systemic Chemot Iago Dillion Lima Cavalcanti,José Cleberson Santos Book 2021 The Editor(s) (if applicabl

[复制链接]
查看: 45689|回复: 39
发表于 2025-3-21 18:12:04 | 显示全部楼层 |阅读模式
期刊全称Advances in Cancer Treatment
期刊简称From Systemic Chemot
影响因子2023Iago Dillion Lima Cavalcanti,José Cleberson Santos
视频video
发行地址Provides comprehensive content on cancer pathophysiology, treatment modalities and antineoplastic chemotherapy in an easy-to-read format.Offers up-to-date information on the target therapies used in c
图书封面Titlebook: Advances in Cancer Treatment; From Systemic Chemot Iago Dillion Lima Cavalcanti,José Cleberson Santos Book 2021 The Editor(s) (if applicabl
影响因子.This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment..We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells. ..The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The p
Pindex Book 2021
The information of publication is updating

书目名称Advances in Cancer Treatment影响因子(影响力)




书目名称Advances in Cancer Treatment影响因子(影响力)学科排名




书目名称Advances in Cancer Treatment网络公开度




书目名称Advances in Cancer Treatment网络公开度学科排名




书目名称Advances in Cancer Treatment被引频次




书目名称Advances in Cancer Treatment被引频次学科排名




书目名称Advances in Cancer Treatment年度引用




书目名称Advances in Cancer Treatment年度引用学科排名




书目名称Advances in Cancer Treatment读者反馈




书目名称Advances in Cancer Treatment读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:51:46 | 显示全部楼层
发表于 2025-3-22 01:46:18 | 显示全部楼层
发表于 2025-3-22 06:58:22 | 显示全部楼层
TTT: A Fast Heuristic to New Theories? the importance of cyclins in the cell division process. This chapter discusses the characteristics of neoplastic cells that differentiate them from tumor cells and the factors that trigger the development of cancer. This chapter also discusses the role of proto-oncogenes in fighting cancer, how the
发表于 2025-3-22 11:01:04 | 显示全部楼层
https://doi.org/10.1007/978-3-319-72787-5rs that help in the diagnosis of cancer. This chapter also focuses on the main tumor markers used in the clinic and their importance in diagnosing the type of cancer in which they are used. Some of the markers are CEA, PSA, PAP, HER-2, BTA, telomerase, K-ras, CA 15.3, CA 19.9, CA 72.4, CA 125, NMP 2
发表于 2025-3-22 13:18:01 | 显示全部楼层
发表于 2025-3-22 20:55:17 | 显示全部楼层
Current and future work, open problems,erapy in the treatment of cancer. We discuss the main classes of immunotherapy, including monoclonal antibodies, tyrosine kinase inhibitors, cancer vaccines, and checkpoint inhibitors, among others. Despite the benefits with the insertion of these immunotherapeutic agents in the cancer clinic, these
发表于 2025-3-22 23:21:03 | 显示全部楼层
发表于 2025-3-23 05:21:14 | 显示全部楼层
发表于 2025-3-23 06:04:11 | 显示全部楼层
https://doi.org/10.1007/978-3-030-68334-4Targeted therapy; Cancer chemotherapy; Pharmaceutical nanotechnology; Cancer vaccines; Immunotherapy; Mon
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-17 13:39
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表